Antibody response to COVID-19 booster vaccine in rituximab-treated patients with anti–neutrophil cytoplasmic antibody–associated vasculitis
Sam Kant, Antoine Azar, Duvuru Geetha
Topics & Concepts
RituximabMedicineVasculitisImmunologyAntibodyCoronavirus disease 2019 (COVID-19)VirologyAnti-neutrophil cytoplasmic antibodySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)PathologyInfectious disease (medical specialty)DiseaseHeparin-Induced Thrombocytopenia and ThrombosisVasculitis and related conditionsDrug-Induced Adverse Reactions